The Italian Job: An Interview with Federico Mingozzi

被引：0

作者：

Davies, Kevin ^{[1
]}

Mingozzi, Federico ^{[2
,3
,4
]}

机构：

[1] Human Gene Therapy, New Rochelle, NY 10801 USA

[2] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA

[3] INSERM, Paris, France

[4] Genethon, Evry, France

来源：

HUMAN GENE THERAPY | 2020年 / 31卷 / 19-20期

关键词：

D O I：

10.1089/hum.2020.29136.int

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

Editor's note:After a distinguished career in academic medicine, including stints at the Children's Hospital of Philadelphia, INSERM and Genethon, Federico Mingozzi joined Spark Therapeutics 3 years ago as chief scientific officer. Mingozzi aims to build on the company's landmark success with Luxturna, the approved therapy for certain retinal diseases such as the type 2 version of Leber's congenital amaurosis. In this exclusive interview withHuman Gene TherapyExecutive Editor Kevin Davies, Mingozzi discusses his career highlights and surveys the hopes and challenges facing the human gene therapy community.

引用

页码：1027 / 1030

页数：4